MDXHF (Medx Health) EBIT per Share: $-0.01 (TTM As of Mar. 2026)


What is Medx Health EBIT per Share?

Medx Health MDXHF EBIT per Share is $-0.01 as of Mar. 2026. The stock has 8 warning signs investors should review. Among 688 Medical Devices & Instruments companies, Medx Health ranks better than 55.38% on this metric.

Medx Health's EBIT per Share for the three months ended in Mar. 2026 was $-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.01.

During the past 3 years, the average EBIT per Share Growth Rate was 12.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was 12.50% per year. During the past 10 years, the average EBIT per Share Growth Rate was 0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Medx Health's EBIT per Share or its related term are showing as below:

MDXHF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -73.5   Med: 6.4   Max: 43.5
Current: 12.6

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Medx Health was 43.50% per year. The lowest was -73.50% per year. And the median was 6.40% per year.

MDXHF's 3-Year EBIT Growth Rate is ranked better than
55.38% of 688 companies
in the Medical Devices & Instruments industry
Industry Median: 9.5 vs MDXHF: 12.60

Medx Health's EBIT for the three months ended in Mar. 2026 was $-0.67 Mil.


Medx Health  (OTCPK:MDXHF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Medx Health EBIT per Share Related Terms


Medx Health EBIT per Share Historical Data

* Premium members only.

The historical data trend for Medx Health's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medx Health EBIT per Share Chart

Medx Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.02 -0.01 -0.01 -0.01

Medx Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 -0.00 -0.00 -0.00

Medx Health EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Medx Health's EBIT per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBIT per Share(A: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-3.285/296.386
=-0.01

Medx Health's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.667/327.932
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.01 mean?
Medx Health (MDXHF) has a EBIT per Share of $-0.01 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medx Health and its competitors. According to the industry distribution chart, Medx Health ranks #307 out of 688 companies in the Medical Devices & Instruments industry, placing it in the top 44.6%.
Is Medx Health's EBIT per Share too high?
Medx Health's current EBIT per Share is $-0.01. Based on the distribution chart, Medx Health ranks #307 out of 688 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Medx Health's EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medx Health ranks #307 out of 688 companies for EBIT per Share. This puts Medx Health in the upper half of its industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medx Health and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medx Health's current EBIT per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medx Health stock overvalued right now?
Based on GuruFocus' analysis, Medx Health (MDXHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.04 — trading 330% above its estimated fair value. The current EBIT per Share is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Medx Health (MDXHF), the current EBIT per Share is $-0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medx Health Business Description

Other Exchanges MDX:Canada
Address 1495 Bonhill Road, Unit 1, Mississauga, ON, CAN, L5T 1M2
Medx Health Corp is engaged in the development, manufacturing, and marketing skin-related screening tools and phototherapy devices for pain relief and tissue repair, marketing the latter in Canada and the United States while the skin related screening tools are also marketed in Europe, Australia and selected markets in Latin America. It offers DermSecure, and MedX Laser Therapy.